biotech / news / / The Tribune
Eli Lilly and Company (India) has issued a high alert warning to patients and healthcare providers following a major crackdown on counterfeit medicines in Haryana.
Counterfeit Mounjaro (tirzepatide) injections worth Rs 56 lakh were seized in Gurugram, Haryana.
KEY POINTS
- The seized fake Mounjaro products were not made by Eli Lilly and did not enter the approved supply chain.
- Eli Lilly's tirzepatide is officially sold in India only as Mounjaro and Yurpeak brands.
- Lilly emphasizes purchasing only through authorized distributors and pharmacies to avoid counterfeit medications.
- The company confirmed that genuine supply channels for Mounjaro remain unaffected by the seizures.
COMPANIES
Summarized by Newsio from The Tribune. How we summarize →